We are live on ! Find out more
AACP

Advantage Alpha Capital Partners Portfolio holdings

AUM $332M
1-Year Est. Return 12.78%
This Fund
S&P 500
This Quarter Est. Return
+8.8%
1 Year Est. Return
+12.78%
3 Year Est. Return
+79.23%
5 Year Est. Return
+110.24%
10 Year Est. Return
–
AUM
$332M
AUM Growth
-$39.1M
Cap. Flow
-$62.1M
Cap. Flow %
-18.72%
Top 10 Hldgs %
18.07%
Holding
140
New
21
Increased
26
Reduced
83
Closed
10
Avg Time Held
6.2 quarters
Top 10 Avg Time Held
0.8 quarters
Top 20 Avg Time Held
1.4 quarters

Top Sells

Rank Stock Value
1
CECO icon
Ceco Environmental
CECO
+$6.18M
2
SN icon
SharkNinja
SN
+$4.32M
3
WK icon
Workiva
WK
+$4.31M
4
MGNI icon
Magnite
MGNI
+$4.3M
5
FTAI icon
FTAI Aviation
FTAI
+$4.01M

Sector Composition

Rank Sector Weight
1 Industrials 35.84%
2 Technology 18.8%
3 Healthcare 15.52%
4 Consumer Discretionary 10.94%
5 Financials 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PTCT icon
126
PTC Therapeutics
PTCT
$5.25B
$221K 0.07%
3,595
-579
-14% -$30.2K
2025 Q2
1 quarter
UMBF icon
127
UMB Financial
UMBF
$9.97B
$220K 0.07%
+1,859
New +$214K
2025 Q3
0 quarters
TCBI icon
128
Texas Capital Bancshares
TCBI
$3.89B
$210K 0.06%
+2,490
New +$213K
2025 Q3
0 quarters
BANF icon
129
BancFirst
BANF
$3.6B
$208K 0.06%
+1,648
New +$213K
2025 Q3
0 quarters
AX icon
130
Axos Financial
AX
$5.04B
$202K 0.06%
+2,388
New +$208K
2025 Q3
0 quarters
AGYS icon
131
Agilysys
AGYS
$2.98B
– –
-23,728
Closed -$2.72M –
BOOT icon
132
Boot Barn
BOOT
$3.63B
– –
-23,136
Closed -$3.52M –
COLL icon
133
Collegium Pharmaceutical
COLL
$718M
– –
-15,531
Closed -$459K –
CSTL icon
134
Castle Biosciences
CSTL
$1B
– –
-16,021
Closed -$327K –
FOLD icon
135
DELISTED
Amicus Therapeutics
FOLD
– –
-35,082
Closed -$201K –
FSS icon
136
Federal Signal
FSS
$7.01B
– –
-32,819
Closed -$3.49M –
KNSA icon
137
Kiniksa Pharmaceuticals
KNSA
$6.18B
– –
-11,020
Closed -$305K –
LGND icon
138
Ligand Pharmaceuticals
LGND
$6.2B
– –
-1,823
Closed -$207K –
PAY icon
139
Paymentus
PAY
$4B
– –
-77,944
Closed -$2.55M –
ZWS icon
140
Zurn Elkay Water Solutions
ZWS
$7.77B
– –
-62,955
Closed -$2.3M –

Similar funds

Advantage Alpha Capital Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Advantage Alpha Capital Partners held 140 positions worth $332M, down 11% from $371M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Advantage Alpha Capital Partners withdrew a net $62.1M in Q3 2025, closing 10 positions and reducing 83 holdings. Its most notable exit was Boot Barn, an estimated $3.52M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 36% of assets, down from 36% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Advantage Alpha Capital Partners opened a new position in Harrow worth $5.37M.

  • Advantage Alpha Capital Partners's largest Q3 2025 buy was Harrow: 111,553 shares worth $5.37M.
  • Advantage Alpha Capital Partners added most to Casella Waste Systems in Q3 2025, an estimated $1.96M increase.
  • Advantage Alpha Capital Partners's biggest Q3 2025 reduction was Ceco Environmental, cutting an estimated $6.18M.
  • Advantage Alpha Capital Partners fully exited Boot Barn in Q3 2025, selling an estimated $3.52M.
  • Advantage Alpha Capital Partners's ten largest holdings make up 18% of its $332M portfolio in Q3 2025.
  • Advantage Alpha Capital Partners opened 21 new positions and closed 10 in Q3 2025.
  • Advantage Alpha Capital Partners's portfolio value fell 11% quarter-over-quarter to $332M.

Based on Advantage Alpha Capital Partners's 13F filing for Q3 2025, filed 12 Nov 2025.